Novartis, UNP, Launch Up-to-$1.8B+ Macrocyclic Peptide Partnership
Novartis will apply Unnatural Products (UNP)’s artificial intelligence (AI)-guided macrocyclic peptide platform to develop next-generation cardiovascular disease therapeutics,…